Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

by NASDAQ Market News February 11, 2020

NASDAQ Market News
Click here to email author

U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test

SELLAS Announces Enrollment of First Patient in Phase 1 Trial of Galinpepimut-S (GPS) in Combination with Nivolumab (Opdivo®) in Patients with Malignant Pleural Mesothelioma (MPM)

Ads